Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi
β Scribed by Jason K. Rivers; Alfred W. Kopf; Anne F. Vinokur; Darrell S. Rigel; Robert J. Friedman; Marcia Levenstein; Edward R. Heilman
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 471 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
A total of 452 patients with dysplastic nevi (DN) were followed prospectively by repetitive, complete cutaneous examinations in order to determine the clinical features of early malignant melanomas (MM) arising in them. Sixteen patients (3.5%) developed 18 newly diagnosed MM during an average follow-up period of 27 months. Twelve of the 18 M M were in situ and all of the primary invasive M M diagnosed prospectively in this follow-up were less than 0.89 mm in Breslow thickness, implying an excellent prognosis. The principal clinical clue to the diagnosis of M M was change in a preexisting pigmented lesion. Totalbody photographs were very useful in helping to identify the early M M in these patients.
π SIMILAR VOLUMES
## Abstract Uveal and cutaneous melanomas differ in tumor biology, immunophenotypes and the demographic correlates of their occurrence. As a means to examine the possibility of some shared etiologic factors, we wished to learn if the 2 cancers occurred in the same individual more often than would b
## BACKGROUND. The aim of the current trial was to assess the efficacy and toxicity of weekly intravenous vinorelbine tartrate with daily oral tamoxifen in the treatment of patients with advanced or metastatic malignant melanoma. ## METHODS. Thirty-one patients were treated with vinorelbine tartr